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Abstract
Background: Post-cardiac arrest (CA) patients are at risk of secondary ischemic damage in the case of suboptimal
brain oxygenation during an ICU stay. We hypothesized that elevated central venous pressures (CVP) would impair
cerebral perfusion and oxygenation (venous cerebral congestion). The aim of the present study was to investigate
the relationship between CVP, cerebral tissue oxygen saturation (SctO2) as assessed with near-infrared spectroscopy
(NIRS) and outcome in post-CA patients.
Methods: This was an observational study in 48 post-CA patients with continuous CVP and SctO2 monitoring
during therapeutic hypothermia.
Results: The relationship between CVP and mean SctO2 was best described by an S-shaped, third-degree
polynomial regression curve (SctO2 = −0.002 × CVP
3 + 0.08 × CVP2 – 1.07 × CVP + 69.78 %, R2 0.89, n = 1,949,108 data
points) with high CVP (>20 mmHg) being associated with cerebral desaturation. Multivariate linear regression
revealed CVP to be a more important determinant of SctO2 than mean arterial pressure (MAP) without important
interaction between both (SctO2 = 0.01 × MAP – 0.20 × CVP + 0.001 × MAP × CVP + 65.55 %). CVP and cardiac output
were independent determinants of SctO2 with some interaction between both (SctO2 = 1.86 × CO – 0.09 × CVP –
0.05 × CO × CVP + 60.04 %). Logistic regression revealed that a higher percentage of time with CVP above 5 mmHg
was associated with lower chance of survival with a good neurological outcome (cerebral performance category
(CPC) 1–2) at 180 days (OR 0.96, 95 % CI 0.92–1.00, p = 0.04). In a multivariate model, the negative association
between CVP and outcome persisted after correction for hemodynamic variables, including ejection fraction
and MAP.
Conclusions: Elevated CVP results in lower brain saturation and is associated with worse outcome in post-CA
patients. This pilot study provides support that venous cerebral congestion as indicated by high CVP may be
detrimental for post-CA patients.
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Background
After cardiac arrest (CA), patients with suboptimal brain
oxygenation during their stay in the intensive care unit
have a large cerebral penumbra and risk of secondary is-
chemic damage [1]. Therefore, thorough knowledge of
the physiological determinants of cerebral oxygen supply
in the post-CA period is paramount for physicians tak-
ing care of these patients. We previously showed that
mean arterial pressure (MAP), mixed venous oxygen
saturation, cardiac output, hemoglobin, partial pressure
of oxygen (PaO2), and carbon dioxide (PaCO2) are im-
portant determinants of cerebral tissue oxygen satur-
ation (SctO2) measured with near-infrared spectroscopy
(NIRS) [2–4]. Current hemodynamic post-CA guide-
lines focus on targeting an MAP of 65 mmHg, based
on the assumption that this would result in optimal
cerebral perfusion assuming normal cerebrovascular
autoregulation [5]. However, cerebral perfusion pres-
sure equals MAP minus intracranial pressure (ICP). As
it has been shown that there is a good correlation be-
tween ICP and central venous pressure (CVP) [6], we
hypothesized that there would be negative correlation
between CVP and cerebral perfusion (venous cerebral
congestion). In this way, cerebral oxygenation might be
compromised in after CA, with elevated CVP due to
right ventricular failure, fluid overload, mechanical
positive pressure ventilation, or pulmonary disease. The
aim of the present study was to investigate the relation-
ship between CVP, SctO2 as assessed with near-infrared




All comatose survivors of non-traumatic CA treated in
our tertiary care hospital (Ziekenhuis Oost-Limburg,
Genk, Belgium) are prospectively enrolled in our data-
base. Patients could have been resuscitated in hospital,
referred by another hospital, or admitted to our own
emergency ward. All patients were treated uniformly ac-
cording to the institutional post-CA protocol. As part of
this protocol, patients are routinely monitored by cere-
bral saturation (SctO2) monitoring on admission to the
coronary care unit. For the purpose of the present study,
we selected patients with continuous CVP recordings
with a 2-sec time interval. Written informed consent
was obtained from a next of kin. The local medical eth-
ics committee approved the study protocol (Ziekenhuis
Oost-Limburg ethical committee, 15/2/2011).
General management
Our institutional post-CA protocol has been described
previously [2–4]. Briefly, all patients were intubated,
mechanically ventilated and sedated with propofol and
remifentanil if hemodynamically tolerated. Cisatracurium
was administered in the case of problematic ventilation
and shivering. Unless an obvious non-cardiac cause could
be identified, all patients were referred for urgent coronary
angiography followed by percutaneous coronary inter-
vention when indicated. Therapeutic hypothermia was
induced shortly after admission by cold saline (4 °C,
30 ml/kg) and further mechanically induced and main-
tained in the coronary care unit by endovascular (Icy-cath-
eter, CoolGard® 3000, Alsius, Irvine, CA, USA) or surface
(ArcticGelTM pads, Arctic Sun® 5000, Medivance, Louis-
ville, CO, USA) cooling systems at 33 °C for 24 h. During
their stay in the ICU, hemodynamic management wasa
performed according to the guidelines. If signs of inad-
equate circulation persisted despite correct fluid resuscita-
tion (wedge pressure >18 mmHg), norepinephrine was
infused with a target MAP >65 mmHg and subsequently
dobutamine to target a cardiac index >2.2 L/min/m2. After
rewarming (0.3 °C/h) sedation was titrated towards the pa-
tient’s comfort with efforts towards minimizing sedation.
Patients were extubated when their neurological, respira-
tory, and hemodynamic status had sufficiently recovered.
Data collection
Cerebral tissue oxygen saturation was continuously mea-
sured with NIRS using the FORE-SIGHT™ technology
(CAS Medical systems, Branford, CT, USA). Sensors
were bilaterally applied to each frontotemporal area be-
fore the start of mechanically induced hypothermia. Sen-
sors were covered to prevent ambient light interference.
Cerebral saturation data were not used to guide
hemodynamic management. Unless contraindicated or
considered inappropriate by treating physicians, all pa-
tients were monitored by a new-generation pulmonary
artery catheter (CCOmbo PAC®, Edwards Life Science,
Irvine, CA, USA) connected to the appropriate monitor
(Vigilance II®, Edwards Life Science, Irvine, CA, USA).
Central venous pressure and cardiac output were mea-
sured continuously by thermodilution. In patients with-
out a pulmonary artery catheter, CVP was measured
using the deep vein catheter accessed through the sub-
clavian or jugular vein. MAP was obtained from a radial
artery line. Both MAP and CVP were measured at the
level of the tragus. Hemodynamic and SctO2 data were
transmitted electronically to a personal computer with a
2-sec time interval, together with information on blood
temperature and oxygen saturation. The ejection fraction
was determined by transthoracic echocardiography.
Statistics
Results are expressed as mean (±SD, standard deviation)
unless otherwise stated. All simultaneously obtained
CVP-SctO2 pairs collected during the first 24 h after
ICU admission were pooled. The mean SctO2 was
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calculated per mmHg CVP (range 0–25 mmHg) and per
mmHg MAP minus CVP (range 40–90 mmHg). Regres-
sion curves were fitted (with calculation of the Pearson
correlation coefficient) to describe the relationship be-
tween SctO2 and CVP. Subsequently, all CVP-SctO2
pairs were stratified according to the simultaneously
obtained MAP (60–70 mmHg, 70–80 mmHg, 80–
90 mmHg, 90–100 mmHg) and cardiac output (2.5–
5 L/min, 5–7.5 L/min, >7.5 L/min) and similar re-
gression analysis was performed. Subsequently, two
separate multivariate linear regression models were
constructed to describe the interactions between
MAP and CVP, and cardiac output and CVP, as de-
terminants of SctO2. We performed trend analysis by
calculating ΔCVP and ΔSctO2 during 1-h time intervals
during the 24-h study period. Finally, the percentage of
time above each CVP value (range 0–25 mmHg) was
calculated per patient. A good outcome was defined
as survival in cerebral performance category (CPC)
1–2 at 180 days. The CPC score ranges from 1 (good
cerebral performance) to 5 (death). Odds ratios (and
95 % CI) were calculated to assess the association be-
tween the time above each CVP value and the odds
to survive with good neurological outcome. Univariate
logistic regression was used to test for significance
(assuming that a higher percentage of time spent
above an optimal CVP level would negatively affect
outcome). Two separate multivariate models were
constructed using backward multivariate logistic regres-
sion. Cardiac arrest variables (patient age, bystander car-
diopulmonary resuscitation (CPR) <10 minutes, shockable
rhythm, time to return of spontaneous circulation
(ROSC), and percentage time with CVP above 5 mmHg)
were included in the first model. Hemodynamic variables
(percentage time with MAP <65 mmHg, ejection fraction,
and percentage time with CVP >5 mmHg) were included
in the second model, Statistical analysis was performed
using Matlab software (version R2010b, Mathworks,




Forty-eight patients were included in the study. Mean
age was 62 ± 13 years, 59 % were male, 84 % received by-
stander CPR, and 68 % had a shockable rhythm. Cardiac
output and filling pressures were continuously moni-
tored with a pulmonary artery catheter in 39 patients
and CVP was monitored by a deep vein catheter in the
remaining 9 patients. Mean MAP was 77 ± 8 mmHg,
mean mixed venous blood oxygen saturation (SVO2) 67
± 10 %, mean cardiac output 3.7 ± 1.2 L/min, and mean
CVP 10 ± 4 mmHg. A summary of the baseline charac-
teristics is provided in Additional file 1.
CVP negatively affects SctO2
The relationship between CVP and mean SctO2 was
best described by an S-shaped, third-degree polynomial
regression curve (SctO2 = −0.002 × CVP
3 + 0.08 × CVP2 −
1.07 × CVP + 69.78 %, R2 0.89, n = 1,949,108 data points),
with low CVP (<5 mmHg) being associated with nor-
mal SctO2 values and high CVP (>20 mmHg) being
associated with cerebral desaturation (Fig. 1a). The rela-
tionship between simultaneously obtained MAP minus
CVP pairs and mean SctO2 was also best described by an
S-shaped, third-degree polynomial regression curve
(SctO2 = 0.0002 × (MAP-CVP)
3 –0.0445 × (MAP-CVP)2 –
3.0959 × (MAP-CVP) – 5.7926 %, R2 0.91) (Fig. 1b).
CVP is more important than MAP as a determinant of SctO2
Subsequently, all CVP-SctO2 pairs were stratified accord-
ing to the simultaneously obtained MAP (60–70 mmHg,
70–80 mmHg, 80–90 mmHg, 90–100 mmHg) (Fig. 2a).
Multivariate linear regression revealed that CVP was
a more important determinant of SctO2 than MAP,
without important interaction between MAP and CVP
(SctO2 = 0.01 ×MAP − 0.20 × CVP + 0.001 ×MAP×CVP
+ 65.55 %). Only when MAP was high (90–100 mmHg,
18 % of data points), was the negative influence of CVP
on SctO2 less pronounced.
Interaction between CVP and cardiac output as
determinants of SctO2
Subsequently, all CVP-SctO2 pairs were stratified ac-
cording to the simultaneously obtained cardiac output
(2.5–5 L/min, 5–7.5 L/min, >7.5 L/min) (Fig. 2b). Multi-
variate linear regression revealed that CVP and cardiac
output are independent determinants of SctO2, with
some interaction between both (SctO2 = 1.86 × CO –
0.09 × CVP – 0.05 × CO × CVP + 60.04 %). When cardiac
output was high (>7.5 L/min, 4 % of data points) there
was no negative correlation between CVP and SctO2.
Trend analysis
We calculated ΔCVP and ΔSctO2 during 1-h time inter-
vals during the 24-h study period. We found significant
correlation between mean ΔSctO2 and mean ΔCVP
during these time intervals (ΔSctO2 = −0.11 × ΔCVP –
0.17, R2 0.36) (Fig. 3).
Outcome
At 180 days, 24 (50 %) of the study patients survived with
CPC 1–2. Logistic regression revealed that a higher per-
centage of time with CVP >5 mmHg was associated with
a lower chance of survival, with a good neurological out-
come at 180 days (OR 0.96, 95 % CI 0.92–1.00, p = 0.04)
(Table 1). In two separate backward multivariate logistic
regression models, the negative association between the
percentage of time with a CVP >5 mmHg and outcome
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persisted after correction for cardiac arrest variables
(model 1) and hemodynamic variables (model 2) (Table 2).
Discussion
This study is the first to support the hypothesis that
venous cerebral congestion due to elevated CVP impairs
cerebral oxygenation and may be detrimental for patients
after CA. First, we showed that there is strong S-shaped
negative correlation between CVP and SctO2. Based on a
previous study, we consider SctO2 between 67 and 69 %
to be optimal for patients after CA [3]. In this way our
physiological model indicates that CVP >5 mmHg results
in SctO2 < 67 % with progressively declining SctO2 with
CVP >20 mmHg.
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Fig. 1 The mean cerebral tissue oxygen saturation (SctO2) is shown per mmHg central venous pressure (a) and the mean SctO2 is shown per
mmHg mean arterial pressure-central venous pressure (MAP-CVP) (b)
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Correlation between paired MAP-CVP measure-
ments and SctO2 was no better when compared to
correlation between CVP and SctO2 alone. CVP
remained an independent determinant of SctO2 in
multivariate models with MAP and cardiac output,
which argues against the hypothesis that high CVP
would be a marker of worse hemodynamics with lower
cardiac output or MAP and for this reason, lower
SctO2. Only in exceptional cases with very high car-
diac output (>7.5 L/min) SctO2 was CVP independent.
We previously showed cerebrovascular autoregulation
to be preserved in the majority of patients after CA
and in these patients SctO2 is relatively MAP-
independent [4]. In contrast to MAP, CVP is the pas-
sive result of fluid status, RV performance and intra-
thoracic pressure and is less prone to active autoregu-
lation. This probably explains why CVP was a more
important determinant of SctO2 than MAP in the
present study. Finally, trend analysis showed moderate
correlation between mean ΔSctO2 and mean ΔCVP
during the same 1-h time intervals. We hypothesize
that this correlation is only moderate, because the ma-
jority of CVP changes during 1-h time intervals are
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Fig. 2 The mean cerebral tissue oxygen saturation (SctO2) per mmHg central venous pressure (CVP) after stratification of the data points
according to the simultaneously obtained mean arterial pressure (MAP) (60–70 mmHg, 70–80 mmHg, 80–90 mmHg, 90–100 mmHg) (a). The
mean SctO2 per mmHg CVP is shown after stratification of the data points according to the simultaneously obtained cardiac output (2.5–5 L/min,
5–7.5 L/min, >7.5 L/min) (b)
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shaped curve will not induce alterations of cerebral
perfusion.
Although not completely comparable to our post-CA
model, the concept of venous congestion being transmitted
to jugular veins leading to cerebral ischemia is supported
by reports that in patients on cardiopulmonary bypass, ob-
struction of the venous cannula elevates CVP followed by
cerebral ischemia as detected with NIRS and cerebral
dysfunction as detected with electroencephalogram
(EEG) or bispectral index (BIS) monitors [7–13]. In
experimental studies in pigs on bicaval cardiopulmonary
bypass, 75 % occlusion of the superior vena cava flow in-
creased CVP to 25 mmHg and ICP to 20 mmHg. This re-
sulted in impaired cerebral perfusion as detected by lower
sagittal sinus and cerebral tissue oxygen saturation. Both
Fig. 3 Trend analysis. The difference in central venous pressure (ΔCVP) and in cerebral tissue oxygen saturation (ΔSctO2) were calculated during
1-h time intervals during the 24-h study period. The mean ΔSctO2 is shown per mmHg mean ΔCVP
Table 1 Odds ratios (OR) for survival with a good neurological
outcome at 180 days (cerebral performance category 1–2) per
percentage of time above each central venous pressure (CVP)
Percentage of time at different CVP values OR 95 % CI P
CVP >1 mmHg 0.19 0.02–2.30 0.19
CVP >2 mmHg 0.46 0.17–1.23 0.12
CVP >3 mmHg 0.69 0.47–1.01 0.05
CVP >4 mmHg 0.90 0.80–1.02 0.10
CVP >5 mmHg 0.96 0.92–1.00 0.04
CVP >6 mmHg 0.97 0.95–1.00 0.07
CVP >7 mmHg 0.98 0.97–1.01 0.19
CVP >8 mmHg 0.99 0.97–1.01 0.34
CVP >9 mmHg 0.99 0.98–1.01 0.45
CVP >10 mmHg 0.99 0.97–1.01 0.52
CVP > 15 mmHg 0.99 0.97–1.02 0.68
CVP > 20 mmHg 0.97 0.87–1.07 0.48
Table 2 Two separate multivariate models constructed using
backward multivariate logistic regression
Model Step 1 Final step
OR (p value) OR 95 % CI P
Model 1: cardiac arrest variables
Age 0.99 (0.84)
Bystander CPR, yes/no 3.75 (0.27)
Shockable rhythm, yes/no 8.93 (0.02) 11.36 1.8–71.5 0.01
Time to ROSC 0.98 (0.63)
Percentage time CVP >5 mmHg 0.94 (0.03) 0.94 0.89–0.99 0.02
Model 2: hemodynamic variables
Percentage time MAP <65 mmHg 0.96 (0.03) 0.96 0.93–0.99 0.04
Ejection fraction, % 0.99 (0.56)
Percentage time CVP >5 mmHg 0.95 (0.03) 0.95 0.90–0.99 0.03
In the first model, arrest variables were included (age, bystander
cardiopulmonary resuscitation (CPR) <10 minutes, shockable rhythm, time to
return of spontaneous circulation (ROSC), and percentage time central venous
pressure (CVP) >5 mmHg) and in the second model, hemodynamic variables
were included (mean, mean arterial pressure (MAP)/24 h, ejection fraction,
mean CO/24 h, percentage time CVP >5 mmHg). Odds ratios (OR) for survival
with a good neurological outcome at 180 days (cerebral performance category
1–2) are shown
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vasopressors and partial relief of the obstruction re-
stored cerebral perfusion pressure and SctO2 to baseline
values. However, only partial relief of the obstruction
reduced ICP [8]. In agreement with our findings, the
influence of CVP on cerebral perfusion was most pro-
nounced in low arterial flow states. In contrast, 50 % ob-
struction of the flow increased CVP to 20 mmHg without
significant decline of the cerebral perfusion, which is in
line with our results showing that mainly CVP above a
critical threshold of 20 mmHg result in pronounced cere-
bral hypoperfusion [9].
Additionally, in patients with traumatic brain injury,
the application of positive end-expiratory pressure
(PEEP) resulted in elevations of CVP, ICP and reductions
of cerebral perfusion pressure, blood flow in the middle
cerebral artery and cerebral desaturation [14–17]. The
detrimental effects of PEEP were more pronounced in
patients with normal respiratory system compliance,
lower CVP, reduced intracranial compliance and low
ICP, all of which favor the transduction of intrapulmon-
ary to intravascular and intracranial pressure.
Second, we showed that the chance of survival with a
good neurological outcome decreases per 1 % of extra time
patients have CVP >5 mmHg. In line with our results, it
has been shown that right ventricular dysfunction predicts
poor outcome in patients after CA independent of left
ventricular function (21). We acknowledge that many con-
founders may bias the link between CVP and outcome. It
can be assumed that patients with higher CVP may have
more preexisting chronic pulmonary disease, more frequent
acute respiratory distress syndrome (ARDS)/acute cor pul-
monale, lower arterial oxygen content, larger myocardial
infarctions or more systolic left ventricular dysfunction, all
of which by themselves may negatively affect the outcome
or influence decisions on withdrawal of ICU therapy. Dis-
proving this theory, the negative association between CVP
and outcome persisted in a multivariate model after correc-
tion for hemodynamic variables, including ejection fraction
and MAP. Moreover, our physiological model supports the
hypothesis that cerebral hypoxia at least partially explains
the link between venous cerebral congestion and worse
outcome. Finally, the arterial PaO2 was not lower in pa-
tients with an average CVP above the median of 10 mmHg.
Potentially, these results have important consequences
for routine clinical practice. The attention to CVP in
modern critical care is waning because it is now gener-
ally accepted that it is a poor and static predictor of fluid
responsiveness in mechanically ventilated patients [18].
Although we acknowledge that it will not be feasible to
maintain normal CVP (<5 mmHg) in the majority of the
mechanically ventilated post-CA patients, our results
indicate that it is at least worth the effort to avoid fluid
overload, treat right ventricular dysfunction appropriately
and manage acute cor pulmonale by a lung-conserving
ventilation strategy in order to keep CVP below 20 mmHg.
In line with our results, a recent study showed an associ-
ation between RV dysfunction and neurological outcome
after cardiac arrest [19]. Future goal-directed treatment
protocols for patients after CA should not only target a
specific MAP but also focus on the other determinants of
cerebral perfusion, including SVO2 and CVP.
We acknowledge that our study has some limitations in-
cluding the lack of direct ICP measurements, invasive bulb
oximetry (which was replaced by NIRS) and absence of ca-
rotid Doppler measurements to directly measure cerebral
pressure, saturation and perfusion. In particular, NIRS
measurements assume a 30/70 partition between the arter-
ial and venous blood compartment. It cannot be excluded
that the venous compartment enlarges in patients with ele-
vated CVP without any change in cerebral blood flow.
Second, this is a small pilot study and these results
should be regarded as hypothesis generating. We cannot
exclude the possibility that our results were inflated as the
1,949,108 data points were collected in 48 patients and
therefore may not be considered independent of each
other. The small sample size most likely explains why pa-
rameters such as bystander CPR and time to ROSC were
not independently associated with outcome in our multi-
variate model. Moreover, the general concept of cerebral
congestion should be validated in other populations in-
cluding patients with traumatic brain injury, severe acute
decompensated heart failure (ADHF) and patients with
high intra-thoracic pressures. In patients with ADHF, ele-
vated CVP, rather than impaired cardiac output or low
MAP, was the main determinant of worsening renal func-
tion during decongestive treatment and it would be inter-
esting to see whether elevated CVP also impairs cerebral
perfusion in patients with ADHF [20].
Third, this was not a randomized controlled interven-
tional trial aiming for a specific CVP. Therefore, it can-
not be excluded that the link between CVP and outcome
is due to confounders and it remains open to further in-
vestigation whether aiming for the lowest feasible CVP
would improve cerebral perfusion and the outcome for
these patients. Finally, CVP measurements were auto-
matically and continuously recorded with 2-sec time in-
tervals. This allowed us to analyze 1,949,108 paired
CVP-SctO2 measurements but had the disadvantage that
automatic recordings are poorly validated against man-
ual measurements and that automatic measurements are
not performed end-expiratory. However, we do not be-
lieve this had a major influence on our results, as a delay
can also be expected between CVP and SctO2 changes.
Conclusion
In conclusion, we showed that CVP above 20 mmHg
results in lower brain saturation and is associated with
worse outcome in patients under therapeutic hypothermia
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after CA. This pilot study provides strong evidence for the
first time that venous cerebral congestion may be detri-
mental for patients after CA. Based on our results, CVP
>20 mmHg should be avoided in patients after CA.
Key messages
 CVP >20 mmHg results in lower brain saturation
and is associated with worse outcome in patients
under therapeutic hypothermia after CA
 CVP >20 mmHg should be avoided in patients
after CA
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